Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of lacosamide oral solution, 10 mg/mL. Glenmark’s lacosamide oral solution, 10 mg/mL is bioequivalent and therapeutically equivalent ...

We have audited the accompanying standalone financial statements of Glenmark Pharmaceuticals Limited (‘the Company), which comprise the Balance Sheet as at 31 March 2024, the Statement of Profit ...

Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. According to the latest Enforcement ...

So the danger was obvious in May, when Indian drugmaker Glenmark Pharmaceuticals recalled nearly 47 million capsules for a dire flaw: The extended-release medication wasn’t dissolving properly ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 46,336.71 Crore) operating in Pharmaceuticals sector. Glenmark Pharmaceuticals Ltd. key ...

Glenmark Pharmaceuticals shares will remain in focus on Thursday after the company acquired a 34% stake in O2 Renewable Energy XXIV Private Limited as part of its commitment to renewable energy ...

Currently, Aurobindo Pharma, Glenmark and Zydus are in the process of recalling their products in the US market due to manufacturing issues. While the concerns around Aurobindo Pharma and Glenmark ...

HDFC Mid-Cap Opportunities Fund (G) 1182.37 77,34,755 1.55 HDFC Mid-Cap Opportunities Fund (IDCW) 1182.37 77,34,755 1.55 HDFC Mid-Cap Opportunities Fund - Direct ...

Glenmark Pharmaceuticals Ltd share price was down by -0.20% from the previous closing price of ₹1,639.35. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...